111 related articles for article (PubMed ID: 31539131)
1. FFAR4 promotes cell proliferation and migration and servers as a potential biomarker for clinicopathological characteristics and prognosis in laryngocarcinoma.
Zhou LZ; Cui YX; Wang WZ; Wu J; Sun Z; Ma SY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7438-7444. PubMed ID: 31539131
[TBL] [Abstract][Full Text] [Related]
2. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma.
Meng FT; Huang M; Shao F; Huang Q
Cancer Biomark; 2018; 23(3):353-361. PubMed ID: 30248044
[TBL] [Abstract][Full Text] [Related]
3. Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.
Ma H; Du X; Zhang S; Wang Q; Yin Y; Qiu X; Da P; Yue H; Wu H; Xu F
Tumour Biol; 2017 Jun; 39(6):1010428317705752. PubMed ID: 28618959
[TBL] [Abstract][Full Text] [Related]
4. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
6. miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway.
Gu J; Han T; Sun L; Yan AH; Jiang XJ
Cell Cycle; 2020 May; 19(9):1012-1021. PubMed ID: 32233984
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
[TBL] [Abstract][Full Text] [Related]
8. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
9. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
[TBL] [Abstract][Full Text] [Related]
10. Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN.
Lu E; Su J; Zeng W; Zhang C
Biomed Pharmacother; 2016 Dec; 84():608-613. PubMed ID: 27694005
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response or oxidative stress induces upregulation of PTPN2 and thus promotes the progression of laryngocarcinoma.
Yang HJ; Yu G; Wang Y; Guo X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4314-4319. PubMed ID: 32373968
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer.
Gao GD; Liu XY; Lin Y; Liu HF; Zhang GJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):422-429. PubMed ID: 29424900
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
14. [Expression of E-cadherin, N-cadherin, β-catenin and their clinical significance in laryngeal carcinoma].
Song PP; Qian XY; Zhou H; Shen XH; Liu DD; Feng AN; Gao X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):440-5. PubMed ID: 27345880
[TBL] [Abstract][Full Text] [Related]
15. MEG3 inhibits cell proliferation, invasion and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma.
Zhao YQ; Liu XB; Xu H; Liu S; Wang JM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2062-2068. PubMed ID: 30915750
[TBL] [Abstract][Full Text] [Related]
16. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
Gong Z; Hu G
Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
[TBL] [Abstract][Full Text] [Related]
17. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
[TBL] [Abstract][Full Text] [Related]
18. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
19. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
20. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
